Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.
Trajectory of fatigue severity in natalizumab treated multiple sclerosis patients.
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis.
Goodbye to all that: a short history of CCSVI.
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
Use of the 2010 McDonald Criteria Can Facilitate Early Diagnosis of Pediatric Multiple Sclerosis in a Predominantly Black Cohort.
Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Validation of the PASAT in Argentina.
Antibodies to MOG in NMO: A seasoned veteran finds a new role.
Mouse Models of Multiple Sclerosis: Experimental Autoimmune Encephalomyelitis and Theiler's Virus-Induced Demyelinating Disease.
Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages.
Empyema presenting as lower extremity weakness.
The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis.
Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature.
Autologous bone marrow transplantation for the treatment of multiple sclerosis.
Neurogenic pulmonary edema in pediatric multiple sclerosis: patient report and summary of cases.
Self-report versus performance measure in gauging level of function with multiple sclerosis.
Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a.
Using EAE to better understand principles of immune function and autoimmune pathology.
Gait and jogging parameters in people with minimally impaired multiple sclerosis.
Targeting ion channels for the treatment of autoimmune neuroinflammation.
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
Revised diagnostic criteria of multiple sclerosis.
In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Pages
« first
‹ previous
…
439
440
441
442
443
444
445
446
447
…
next ›
last »